2.Effects of transcranial direct current stimulation on sleep disorders in Parkinson's disease:a randomized,single-blind controlled trial
Jianjun LU ; Yu HAN ; Qiumin YU ; Jiawen LIU ; Minghua ZHU ; Jinzhi LIN ; Yang ZHANG ; Yong ZHANG ; Jinjian WANG
The Journal of Practical Medicine 2024;40(11):1488-1493
Objective To investigate the efficacy of transcranial direct current stimulation(tDCS)on sleep disorder in patients with Parkinson's disease(PD).Methods From July 2021 to July 2023,patients with PD and sleep disorders in the Department of Neurosurgery of the Second People's Hospital of Guangdong Province were selected.The enrolled patients were divided into sham stimulation group(n=28)and true stimulation group(tDCS)(n=29)according to the inclusion and exclusion criteria.MDS-UPDRS,PDSS and other rating scales were used to evaluate the patients.Before and after tDCS treatment,MS-11 was used for intelligent sleep monitor-ing.The baseline and improvement of sleep disorders in the two groups before and after treatment were analyzed.Results Before tDCS treatment,there was no significant difference in general conditions and scale scores between the two groups(P>0.05).There was no significant difference in polysomnographic monitoring results between the two groups before treatment(P>0.05).Compared with pre-treatment,there was no significant difference in sleep monitoring results in the sham stimulation group(P>0.05),while the sleep duration and sleep efficiency signifi-cantly increased,the nighttime awakening duration,nighttime awakening frequency,MDS-UPDRS-Ⅲ score,and LEDD dose significantly decreased in the true stimulation group,with statistical significance(P<0.05).Conclusion Pharmacological treatment combined with tDCS treatment is effective for sleep disorders and motor function in patients with PD,which could increase the sleep duration and sleep efficiency of PD patients with sleep disorders to a certain extent,reduce the nighttime awakening duration and frequency,thereby improving the fatigue symp-toms during the daytime,and improving the efficacy of conventional pharmacological treatment for PD.
3.Clinical study and prognosis analysis of Shenfu injection combined with ulinastatin in the adjuvant treatment of septic shock
Xing ZHANG ; Xin WANG ; Qiang ZHOU ; Jinjian ZHANG
China Modern Doctor 2024;62(19):89-92
Objective To explore the clinical effect of Shenfu injection combined with ulinastatin in the adjuvant treatment of septic shock.Methods Ninety-one patients with septic shock treated in Handan Central Hospital from January 2022 to June 2023 were selected as the study objects,and were divided into treatment group(47 cases)and control group(44 cases)according to random number table method.Both groups were given conventional treatment,the control group was given ulinastatin injection,and the treatment group was given Shenfu injection combined with ulinastatin injection.The levels of superoxide dismutase(SOD),malondialdehyde(MDA),nitric oxide(NO),interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α)before treatment and 1,3 and 7 days after treatment,as well as the time of admission to emergency intensive care unit(EICU)and 28 days mortality were compared between two groups.Results The duration of EICU stay in treatment group was significantly shorter than that in control group,and the 28 days mortality was significantly lower than that in control group(P<0.05).After 1,3 and 7 days of treatment,the serum levels of TNF-α,IL-6,MDA and NO in two groups were significantly lower than before treatment,the SOD level in treatment group was significantly higher than before treatment,and the SOD level in control group first decreased and then increased(P<0.05).The serum levels of TNF-α,IL-6,MDA and NO in treatment group were significantly lower than those in control group,and the level of SOD was significantly higher than that in control group(P<0.05).Conclusion On the basis of conventional treatment,Shenfu injection combined with ulinastatin can further inhibit the release of inflammatory factors,reduce the level of oxidative stress,shorten the time of patients staying in EICU,reduce the 28d mortality,and provide a new idea for the treatment of septic shock.
4.A case report of glans penis hemangioma
Zhaoyang LIU ; Zhengguo ZHANG ; Congwei WANG ; Changguo WANG ; Jianhua ZHU ; Zhankui JIA ; Jinjian YANG
Chinese Journal of Urology 2024;45(3):229-230
Hemangioma of the penile head is rare. This paper reported a patient, 16 years old, who was admitted to hospital due to the discovery of multiple masses on the head of the penis for more than two years. Physical examination showed that three vascular mass-like masses were distributed along the coronal sulcus at the 3, 9, and 12 points of the penile head, and the larger one was about 10 mm×5 mm size, blue-purple, soft, and painless. Ultrasound examination suggested that the patient had a penile head hemangioma. Surgical resection was performed, and the postoperative pathological diagnosis was penile head hemangioma.The follow-up of 3 months showed that the wound healed well without recurrence, and the penile head appearance was not obviously deform.
5.Efficacy and safety of PD-1 inhibitors combined with chemotherapy versus chemotherapy alone in patients with metastatic bladder cancer
Congwei WANG ; Qizhe WU ; Yuankang FENG ; Bo FU ; Zhaoyang LIU ; Zhengguo ZHANG ; Jinjian YANG ; Zhankui JIA
Chinese Journal of Urology 2023;44(11):806-811
Objective:To compare the efficacy and safety of programmed death-1(PD-1)inhibitors in combination with chemotherapy versus chemotherapy alone in patients with metastatic bladder cancer.Methods:A retrospective analysis was performed on the clinical data of 77 cases of metastatic bladder cancer who were admitted to the First Affiliated Hospital of Zhengzhou University from January 2014 to October 2022. According to the different clinical treatment regimens, they were divided into two groups. Patients treated with PD-1 inhibitors combined with gemcitabine and cisplatin (GC) regimen were referred to as IGC group, and patients who received GC chemotherapy alone were referred to as GC group. There were 24 cases in IGC group, including 18 males and 6 females, with a median age of 60 (56, 67) years old. Seventeen cases had a history of smoking. Fifteen cases had an Eastern Cooperative Oncology Group (ECOG) score of 0 and 9 cases had a score of 1. Twenty-three cases suffered distant metastasis (stage M 1). Two cases suffered lymph node metastasis only, 6 cases with liver metastasis, 8 cases with lung metastasis, and 8 cases with bone metastasis. There were 53 cases in GC group, including 45 males and 8 females, with a median age of 63 (55, 69) years old. Thirty-one cases had a history of smoking. Thirty cases had an ECOG score of 0 and 23 cases had a score of 1, 48 cases suffered stage M 1, 2 cases suffered lymph node metastasis only. Nineteen cases suffered liver metastasis. Twenty-seven cases suffered lung metastasis. And 23 cases suffered bone metastasis. There was no statistically significant difference in the above general information between the two groups ( P>0.05). Kaplan-Meier method was used to plot the survival curves, and the difference of median progression-free survival (mPFS) and median overall survival (mOS) between the two groups was compared by log-rank test. Finally, the difference in adverse reactions between the two groups was compared. Results:The objective response rate (ORR) was 41.7% and the disease control rate (DCR) was 87.5% in the IGC group.As a comparison, the ORR was 43.4% and the DCR was 83.0% in the GC group. The differences in ORR ( P=0.887) and DCR ( P=0.871) between the two groups were not statistically significant. All patients were followed up for 3 to 45 months, with a median follow-up time of 24 (14, 43) months. The mPFS was 7.0 (95% CI 5.7-8.3) months in the GC group and 8.0 (95% CI 3.0-13.1) months in the IGC group, and the difference was statistically significant between the two groups ( P=0.026). The mOS of patients in the GC group was 16.0 (95% CI 14.4-17.6) months, the mOS was not yet reached in the IGC group, and patients in the IGC group had longer mOS with a statistically significant difference ( P=0.022). All patients experienced treatment-related adverse reactions. Grade 3-4 adverse reactions occurred in 8 cases (33.3%) in the IGC group and in 16 cases (30.2%) in the GC group, and no adverse reaction-related deaths were observed( P=0.992). The most common adverse reactions in both groups were anemia, including 18 cases (75.0%) in IGC group and 38 cases (71.7%) in GC group. There were 4 cases (16.7%) of grade 1-2 hypothyroidism in the IGC group but no patients with hypothyroidism were found in the GC group, and the difference was statistically significant ( P=0.012). There were 8 cases (33.3%) and 4 cases (7.5%) of grade 1-2 skin adverse reactions in the IGC and GC groups, respectively, and the difference was statistically significant ( P=0.011). The immune-related adverse reactions of PD-1 inhibitors in IGC group were 1 case of hyperthyroidism (4.2%), 4 cases of hypothyroidism (16.7%), 1 case of adrenal insufficiency (4.2%), and 1 case of immune colitis (4.2%). Conclusions:Compared with chemotherapy alone, PD-1 inhibitors combined with chemotherapy for metastatic bladder cancer can effectively prolong the mPFS and median mOS. The adverse reactions of the two groups were tolerable, and there was no significant difference in the incidence of grade 3-4 adverse reactions. In general, PD-1 inhibitors combined with chemotherapy in the treatment of metastatic bladder cancer is safe and feasible, but attention should be paid to the immune-related adverse reactions of PD-1 inhibitors.
6.Identification of Bulbocodin D and C as novel STAT3 inhibitors and their anticancer activities in lung cancer cells.
Xinyu HE ; Jiarui FU ; Wenyu LYU ; Muyang HUANG ; Jianshan MO ; Yaxin CHENG ; Yulian XU ; Lijun ZHENG ; Xiaolei ZHANG ; Lu QI ; Lele ZHANG ; Ying ZHENG ; Mingqing HUANG ; Lin NI ; Jinjian LU
Chinese Journal of Natural Medicines (English Ed.) 2023;21(11):842-851
Cancer stands as one of the predominant causes of mortality globally, necessitating ongoing efforts to develop innovative therapeutics. Historically, natural products have been foundational in the quest for anticancer agents. Bulbocodin D (BD) and Bulbocodin C (BC), two bibenzyls derived from Pleione bulbocodioides (Franch.) Rolfe, have demonstrated notable in vitro anticancer activity. In human lung cancer A549 cells, the IC50s for BD and BC were 11.63 and 11.71 μmol·L-1, respectively. BD triggered apoptosis, as evidenced by an upsurge in Annexin V-positive cells and elevated protein expression of cleaved-PARP in cancer cells. Furthermore, BD and BC markedly inhibited the migratory and invasive potentials of A549 cells. The altered genes identified through RNA-sequencing analysis were integrated into the CMap dataset, suggesting BD's role as a potential signal transducer and activator of transcription 3 (STAT3) inhibitor. SwissDock and MOE analyses further revealed that both BD and BC exhibited a commendable binding affinity with STAT3. Additionally, a surface plasmon resonance assay confirmed the direct binding affinity between these compounds and STAT3. Notably, treatment with either BD or BC led to a significant reduction in p-STAT3 (Tyr 705) protein levels, regardless of interleukin-6 stimulation in A549 cells. In addition, the extracellular signal-regulated kinase (ERK) was activated after BD or BC treatment. An enhancement in cancer cell mortality was observed upon combined treatment of BD and U0126, the MEK1/2 inhibitor. In conclusion, BD and BC emerge as promising novel STAT3 inhibitors with potential implications in cancer therapy.
Humans
;
Lung Neoplasms/metabolism*
;
STAT3 Transcription Factor/metabolism*
;
Antineoplastic Agents/chemistry*
;
A549 Cells
;
Apoptosis
;
Cell Line, Tumor
;
Cell Proliferation
7.A followup study on academic pressure and Internet addiction of college students in Jiangsu
Chinese Journal of School Health 2022;43(4):574-577
Objective:
To examine the longitudinal relationship between academic pressure and Internet addiction of college students and to provide reference for the development of college students mental health.
Methods:
In October 2016, a longitudinal 4 waves (T1 to T4) of follow up study was conducted among 5 372 college students from a university in Jiangsu, with an interval of 1 year each time. Academic pressure and Internet addiction were derived from the College Students Mental Health Screening Scale. A cross lag analysis was used to explore the relationship between college students academic pressure and Internet addiction.
Results:
Repeated measures analysis of variance showed that the main effect of time for academic pressure was significant[ F(3,16 113)= 767.28 , P<0.01,η 2=0.13]. The academic pressure of college students showed a downward trend over time, with the highest at T1 stage and the lowest at T4 stage. The main effect of time for college students Internet addiction was significant[ F(3,16 113)= 165.22 , P<0.01, η 2=0.03]. The Internet addiction of college students showed a trend of decreasing after increasing over time, with the highest stage T2 and the lowest stage T4. The cross lag analysis showed that academic pressure of T1 could significantly predict the Internet addiction of T2, and academic pressure of T3 could significantly predict the Internet addiction of T4, and the path coefficients are 0.07 and 0.07( P <0.01). In addition, the pre test (T n ) Internet addiction can significantly predict the post test [T( n +1)] academic pressure, and the path coefficients were 0.06, 0.06, 0.08( P <0.01).
Conclusion
Academic pressure can partially predict Internet addiction among college students, while Internet addiction can also significantly predict academic pressure. Colleges and universities should strengthen the construction of learning style, reduce the academic pressure of students,and reduce the Internet addiction of college students through various ways, so as to promote the healthy development of college students.
8.Clinical characteristics and prognostic analysis of renal primary neuroendocrine neoplasms
Chunsen WEN ; Long ZHANG ; Yu LIU ; Qizhe WU ; Wencheng YAO ; Songchao LI ; Zhankui JIA ; Jinjian YANG
Chinese Journal of Urology 2022;43(6):423-429
Objective:To investigate the clinicopathological characteristics, treatment methods and prognosis of renal primary neuroendocrine neoplasms.Methods:The clinical data of 42 patients with renal neuroendocrine neoplasms admitted to the First Affiliated Hospital of Zhengzhou University from October 2011 to June 2021 were retrospectively analyzed.There were 17 males and 25 females. The median age was 60.0 (50.0, 67.0) years old.The CT enhancement scan lesion was slightly intensified with less intensification than normal renal parenchyma.The clinic manifestation included lumbar abdominal pain in 7 cases, hematuria in 3 cases, abdominal distension in 1 cases, and asymptomatic in 8 cases. The average diameter of tumor was 8.0 (4.0, 10.0) cm. The tumor of 13 cases was in the left, and 6 cases was in the right. 6 cases were in T 1 stage, 11 cases were in T 2, 11 cases were in T 3, and 14 cases were in T 4.17 cases had lymph node metastasis, 11 cases had distant metastasis.The surgical method was radical nephrectomy in 27 cases, nephrectomy in 5 cases and interventional embolization in 4 case, and no operation in 6 cases, including 5 with chemotherapy alone and 1 with supportive care.Patients were classified by WHO Classification of renal tumors of the urinary system and the male reproductive organs (2016) into high-differentiated renal neuroendocrine tumors (NET, including carcinoid and atypical carcinoids) and high-grade renal neuroendocrine carcinoma (NEC, including small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma). The clinicopathological characteristics and prognosis of the 2 groups were compared, and the Cox proportional regression risk model was used to analyze the clinical factors affecting the prognosis. Results:In the NET group, 12 cases were carcinoids and 7 cases were atypical carcinoids. In the NEC group, 23 cases were small cell carcinomas.The mean Ki-67 index of 42 cases was 35% (4.5%, 62.5%). The proportion of positive expression of the neuroendocrine markers CD56, chromogranin A (CgA), and synapsin (Syn) were (37/42), (15/42), and (38/42), respectively. A total of 42 patients were followed up, and the median follow-up time was 60 (35, 99) months, and the median survival time was 25 (15, 60) months. The 3-year and 5-year overall survival rates were 40.0% and 21.2%. The 3-year and 5-year overall survival rates in the NET group were 72.6% and 42.3%.The 3-year and 5-year overall survival rates in the NEC groups were 6.3% and 0, respectively. The mean Ki-67 index was 3% (2%, 10%) in the NET group, 2 patients received postoperative chemotherapy and 3 patients had early progression after initial treatment.The mean Ki-67 index in the NEC group was 60% (40%, 80%), 15 patients received postoperative chemotherapy, and 13 patients had early progression of initial treatment.There were statistically differences in treatment method, postoperative chemotherapy, Ki-67 index, and early disease progression (all P <0.05) between the two groups.The results of univariate analysis showed that sex, age, early progression, treatment method, tumor differentiation, and Ki-67 index were all factors influencing patient prognosis (all P <0.05). Cox multivariate analysis showed that poorly differentiated NEC ( HR=13.964, P=0.003) and early progression ( HR=3.626, P=0.018) were independent risk factors for patient survival, and renal radical surgery ( HR=0.197, P=0.033) was independent protective factors for patient survival. Further subgroup analysis showed that the median survival time of the NEC patients with adjuvant chemotherapy after surgery was significantly longer compared with the patients without adjuvant chemotherapy (21 and 9 months, P=0.012). Conclusions:Primary renal neuroendocrine tumors are clinically rare, often manifested as lumbar and abdominal pain, and radical renal surgical treatment is preferred.The NET has a better prognosis and NEC prognosis is extremely poor, but NEC patients can have survival benefit from chemotherapy. NEC and early progression of the disease are independent prognostic risk factors, and radical renal surgical treatment is an independent protective factor for prognosis.
9.A 4-year follow up study on suicidal ideation of college students in one university
Chinese Journal of School Health 2021;42(10):1524-1526
Objective:
To explore the dynamic changes of suicidal ideation in college students, and to provide evidence for the early prevention and intervention of suicidal ideation.
Methods:
A cluster sampling of 5 372 college students from one university in Jiangsu was selected and followed up for four years (2016—2019) using the College Students Mental Health Screening Scale.
Results:
The detection rates of suicidal ideation among college students in the first to four (T1-T4) stages were 4.36%, 8.99%, 7.32 %, and 5.90%, respectively, showing decreasing after increasing trend. Stage T2 was the turning point, and the trend of change was significantly different ( P <0.01). The detection rate of suicidal ideation of girls in T1 stage was significantly higher than that of boys ( χ 2=10.55, P <0.01). In the T1-T2 stages, the rate of suicidal idea detection among boys increased faster than that of girls, and the rate of boys in T4 stage surpassed that of girls. The detection rate of suicidal ideation in T1-T4 stage of students in big cities was higher than that of students in small and medium sized cities, towns and rural areas, and the difference in stage T4 was very significant ( χ 2=32.11, P <0.01). The contingency table analysis found that the proportion of suicidal ideation at the same time in the two stages before and after was between 18.63%-35.04% ( P <0.01). There was no suicidal ideation in the previous stage, and the proportion of suicidal ideation in the latter stage was between 4.48%-7.80% ( P <0.01). There were 11 participants who had suicidal ideation in the T1-T4 stages, accounting for 0.20% of the total number, and 4.70% of the suicidal ideation number.
Conclusion
Colleges and universities should pay more attention to suicidal ideation prevention for vulnerable groups in important periods, and grasp the dynamic information of students through a variety of ways.
10.Analysis of recurrent and prognosis factors of primary retroperitoneal liposarcoma
Daling ZHANG ; Yafei DING ; Xinquan ZHANG ; Huhuang ZOU ; Tao WANG ; Jun WANG ; Wencheng YAO ; Zhankui JIA ; Xiaowei DANG ; Jinjian YANG
Chinese Journal of Urology 2021;42(2):137-143
Objective:To investigate the factors related to recurrence and prognosis of retroperitoneal liposarcoma.Method:The clinical data of patients with primary retroperitoneal liposarcoma who underwent surgical treatment in the First Affiliated Hospital of Zhengzhou University from June 2011 to January 2020 were analyzed retrospectively. There were 42 males and 47 females and patients’median age was 53 (26-78). Sixty-five cases were treated by operation in our hospital, and 24 cases were primarily treated by the operation in another hospital. The clinical manifestations of the initial diagnosis included retroperitoneal mass in 41 cases, abdominal distension in 12 cases, abdominal pain in 10 cases, fever in 11 cases, nausea, vomiting and poor appetite in 8 cases, frequent urination and dysuria in 6 cases, and bilateral lower limb edema in 1 case. Preoperative CT imaging showed that the tumor body was located in the retroperitoneal kidney area in 58 cases, while in the retroperitoneal space or the pelvic extraperitoneal space in 31 cases. There were 55 single cases and 34 multiple cases. The median tumor length was 20(3-52) cm. Among the primarily treated 65 patients, 47(72.3%) were considered as primary retroperitoneal liposarcoma by preoperative imaging examination. Among the 89 patients treated by surgery, 78 underwent endoscopic surgery, among which 21 underwent laparoscopic surgery, 38 cases of retroperitoneal laparoscopic surgery, 19 cases of Da Vinci robot-assisted laparoscopic surgery. Open operation was performed in 11 cases. There were 87 patients undergoing radical resection and 2 patients undergoing palliative resection. Forty-two patients underwent intraoperative combined resection of the adjacent organs. The recurrence and survival status of patients were followed up.Results:All the 89 patients underwent the operation successfully, with the median operative blood loss of 200 (10-2000) ml. There were 23 cases being diagnosed of well differentiated liposarcoma, 40 cases of dedifferentiated, 20 cases of myxoid/round, 5 cases of myxoid liposarcoma, and 1 cases of mixed type. Pathologically, there 42 cases with low grade histology and 47 cases with high grade histology. In this study, 89 patients were followed up for 3 to 108 months, and the median follow-up time was 28 months. The 5-year recurrence free survival rate, disease-free survival rate and overall survival rate of the patients were 16.7%, 16.1% and 52.6%, respectively. There were 57 patients presenting local recurrence, 1 patient of lung metastasis, and 1 patient of liver metastasis, and the median disease-free survival time was 24 months. There were 42 patients died of the disease, with a median survival time of 64 months. Univariate analysis showed that intraoperative blood loss( P<0.01), whether multiple cases( P<0.01), pathologic types( P<0.01), and histological grades ( P<0.01) were related to disease-free survival.The intraoperative blood loss( P<0.01), multiple cases( P<0.05), pathologic types ( P<0.05), and recurrence ( P<0.01)were related with overall survival. Gender, age, tumor size, tumor location, whether primary surgery, radical resection or combined resection of adjacent organ had no effect on the prognosis of patients ( P>0.05). Cox regression model multivariate analysis revealed that surgical bleeding ( RR=2.360, 95% CI 1.313-4.241, P=0.004), multiple tumor ( RR=1.899, 95% CI 1.068-3.375, P=0.029), and pathological type ( RR=4.976, 95% CI 1.622-15.264, P=0.005) were independent factors affecting disease-free survival. The recurrence was an independent factor affecting the overall survival of patients ( RR=31.495, 95% CI 1.062-933.684, P=0.046). Conclusions:Retroperitoneal liposarcoma is a rare disease with high recurrence rate. The intraoperative blood loss, whether multiplicity and pathological type are independent factors affecting the disease-free survival, and recurrence is independent factors affecting the overall survival.


Result Analysis
Print
Save
E-mail